Ambeed.cn

首页 / 抑制剂/激动剂 / 其他抑制剂/激动剂 / / Doxifluridine

去氧氟尿苷 /Doxifluridine {[allProObj[0].p_purity_real_show]}

货号:A137458 同义名: 5'-脱氧-5-氟尿苷 / 5'-DFUR;5-Fluoro-5'-deoxyuridine

Doxifluridine is a thymidine phosphorylase activator for PC9-DPE2 cells with IC50 of 0.62 μM.

Doxifluridine 化学结构 CAS号:3094-09-5
Doxifluridine 化学结构
CAS号:3094-09-5
Doxifluridine 3D分子结构
CAS号:3094-09-5
Doxifluridine 化学结构 CAS号:3094-09-5
Doxifluridine 3D分子结构 CAS号:3094-09-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Doxifluridine 纯度/质量文件 产品仅供科研

货号:A137458 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell Host Microbe, 2024. Ambeed. [ A163338 ]
Cancer Res., 2024. Ambeed. [ A295334 ]
J. Pharm. Investig., 2024. Ambeed. [ A221527 , A691302 , A272538 , A187261 ]
J. Fungi, 2024, 10(11): 751. Ambeed. [ A796919 ]
JBC, 2024, 107935. Ambeed. [ A194396 ]
更多 >
产品名称 Phosphorylase 其他靶点 纯度
Tipiracil hydrochloride 98%
CP-91149 +++

Glycogen phosphorylase (GP), IC50: 0.13 μM

98+%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Doxifluridine 生物活性

描述 In tumors, doxifluridine is converted to 5-FU by thymidine phosphorylase (TP). TP, also known asplatelet-derived endothelial cell growth factor, is upregulated in many solid tumors including breast, prostate and colorectal cancers. Elevated levels of TP are associated with tumor aggressionand poor prognosis. Doxifluridine, a derivative of 5-fluorouracil (5-FU) with less severe systemic toxicity, is a TP activator and widely used to treat various cancers. Doxifluridine significantly inhibited tube formation compared with the untreated control group (P< 0.0001). Doxifluridine at 10 μM significantly suppressed VEGF (vascular endothelial growth factor) expression in FU-MMT-1 cells compared with the control group in vitro (P< 0.01). Low-dose doxifluridine (1 μM) slightly increased TSP-1 expression (P = 0.272) in HUVEC, whereas high-dose doxifluridine (100 μM) reduced TSP-1 expression. Low-dose doxifluridine (1 and 10 μM) significantly increased TSP-1 expression in FU-MMT-1 cells compared with the control group (1 μM, P = 0.041; 10 μM, P = 0.0089). Further, doxifluridine (100 μM) reduced the proliferation of HUVEC compared with the control group. Administration of doxifluridine in combination with TNP-470 showed significantly greater suppression of tumor growth compared with either treatment alone. Following treatment, the tumor completely disappeared in five of six (83.3%) mice treated with the MTD (maximum tolerated dose) of doxifluridine in combination with TNP-470[1].

Doxifluridine 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02494596 - Completed - -
NCT00842244 Stomach Neoplasms ... 展开 >> Advanced Gastric Cancer 收起 << Phase 1 Completed - Japan ... 展开 >> Pfizer Investigational Site Kashiwa, Chiba, Japan Pfizer Investigational Site Yufu-city, Oita, Japan Korea, Republic of Pfizer Investigational Site Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Pfizer Investigational Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 收起 <<
NCT00925769 Pancreatic Cancer Phase 1 Completed - Austria ... 展开 >> Vienna, Austria, 1100 Wien, Austria, 1130 收起 <<

Doxifluridine 参考文献

[1]Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts

[2]Berne M, Gustavsson B, et al. Inhibition of thymidylate synthase after administration of doxifluridine in a transplantable colon carcinoma in the rat. Cancer Invest. 1988;6(4):377-83.

Doxifluridine 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.06mL

0.81mL

0.41mL

20.31mL

4.06mL

2.03mL

40.62mL

8.12mL

4.06mL

Doxifluridine 技术信息

CAS号3094-09-5
分子式C9H11FN2O5
分子量 246.192
别名 5'-脱氧-5-氟尿苷 ;5'-DFUR;5-Fluoro-5'-deoxyuridine;5'-Deoxy-5-fluorouridine.;doxyfluridine;Flutron;Furtulon;5-DFUR;AMC 0101;Ro 21-9738
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Inert atmosphere,Room Temperature

溶解度

DMSO: 105 mg/mL(426.5 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 20 mg/mL(81.24 mM),配合低频超声助溶

DMF: 100 mg/mL(406.19 mM),配合低频超声助溶

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。